P2.02 Second-line Afatinib vs Erlotinib for Advanced Lung Squamous Cell Carcinoma: Final Analysis of the Phase 3 LUX-Lung 8 Trial
Makaleler > Tam Makale · 2019
Yazarlar: G.D. Goss, M. Cobo, S. Lu, K. Syrigos, K.H. Lee, Erdem GÖKER, V. Georgoulias, W. Li, D. Isla, A. Morabito, Y.J. Min, A. Ardizzoni, H. Jian, Y. Yu, S. Bender, A. Cseh, E. Felip
Journal of Thoracic Oncology, Uluslararası, Wos, 2019, cilt 14, ss S1185-S1185